{"transactions":[{"id":3342108,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":153134,"kind":"person","name":"Ceed2Med LLC","position":1,"cik":"0001764452","reported_name":"Ceed2Med LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153135,"kind":"person","name":"Yampolsky Vladislav","position":2,"cik":"0001782054","reported_name":"Yampolsky Vladislav","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, Par Value $0.0001 per Share","published_at":"2019-12-13T22:39:04.000Z","date":"2019-12-11","kind":"other","acquired":false,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Exactus, Inc. (the \"Issuer\"), par value $0.0001 per share (\"Shares\"), that were distributed by Ceed2Med, LLC (\"C2M\") to one of its non-managing members in connection with its internal operational purposes."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This statement is jointly filed by and on behalf of each of C2M and Mr. Vladislav Yampolsky (the \"Reporting Persons\").  Mr. Yampolsky is the Managing Member of C2M.  As such, Mr. Yampolsky may be deemed to beneficially own securities owned by C2M."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Reporting Persons state that neither the filing of this statement nor anything herein shall be deemed an admission that such persons are, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\") or otherwise, the beneficial owners of any securities covered by this statement. The reporting persons disclaim beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such persons in such securities."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Represents Shares directly beneficially owned by C2M."}],"balance_after":6435691,"source":{"system":"sec-edgar","filing":"0001415889-19-001504","document":"form4-12132019_021251.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919001504/form4-12132019_021251.xml","form_type":"4"}},{"id":3495350,"issuer":{"id":9699,"kind":"organization","name":"PANACEA LIFE SCIENCES HOLDINGS, INC."},"owners":[{"id":153134,"kind":"person","name":"Ceed2Med LLC","position":1,"cik":"0001764452","reported_name":"Ceed2Med LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-06-10T21:27:49.000Z","date":"2019-06-06","kind":"disposition_to_issuer","acquired":false,"shares":750000,"price":0.3,"value":225000.0,"ownership":{"direct":true},"balance_after":7635690,"source":{"system":"sec-edgar","filing":"0001415889-19-000686","document":"form4-06102019_020635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1552189/000141588919000686/form4-06102019_020635.xml","form_type":"4"}}]}